Cargando…
A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
Non-invasive, immuno-dynamic, biomarkers positioned in cancer patient’s blood milieu with immuno-oncological applications are rare. We recently established a “first-in-class” serum functional immunodynamics status (sFIS) assay, wherein in vitro assessment of serum-induced myeloid NFkB and/or interfe...
Autores principales: | Sprooten, Jenny, Coosemans, An, Garg, Abhishek D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757472/ https://www.ncbi.nlm.nih.gov/pubmed/35036075 http://dx.doi.org/10.1080/2162402X.2021.2024692 |
Ejemplares similares
-
Immunodynamics of explanted human tumors for immuno‐oncology
por: Dubuisson, Agathe, et al.
Publicado: (2020) -
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
por: Kohrt, Holbrook E., et al.
Publicado: (2016) -
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020) -
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020) -
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2022)